Introduction: Orexin-A is a 33-amino-acid peptide used as a reference compound in laboratory research. This overview covers its structure, synthesis, and in vitro study applications only, with no medical or therapeutic discussion.
Structure and Synthesis
Orexin-A contains two intrachain disulfide bridges and an amidated C-terminus, features that make correct oxidative folding a key step in its solid-phase synthesis. The peptide is purified by preparative reversed-phase HPLC and confirmed by mass spectrometry. Purity is assessed by analytical HPLC, and net peptide content is determined before use in quantitative laboratory assays so experimental concentrations are based on verified material.
In Vitro Study Applications
- Cell culture models examining peptide-receptor signaling readouts under controlled laboratory conditions
- Assay development using a well-characterized reference peptide
- Comparative studies of peptide analogues in vitro
- Stability and degradation studies in buffer and culture media conditions
Analytical Notes
Researchers typically confirm identity by mass spectrometry, purity by RP-HPLC, and content by amino acid analysis or quantitative methods before use, since compound quality directly affects reproducibility across experiments. Correct disulfide pairing is verified as part of characterization, because misfolded forms can behave differently in vitro.
References
Published laboratory literature on orexin-A in experimental models; standard peptide synthesis and characterization literature.
Disclaimer: This article is for laboratory research education only. All products referenced are not for human consumption / research use only. No medical, therapeutic, dosing, or efficacy information is provided or implied.